Abstract Multiscale agent-based modeling (MABM) has been widely used to simulate Glioblastoma Multiforme (GBM) and its progression. At the intracellular level, the MABM approach employs a system of ordinary differential equations to describe quantitatively specific intracellular molecular pathways that determine phenotypic switches among cells (e.g. from migration to proliferation and vice versa). At the intercellular level, MABM describes cell-cell interactions by a discrete module. At the tissue level, partial differential equations are employed to model the diffusion of chemoattractants, which are the input factors of the intracellular molecular pathway. Moreover, multiscale analysis makes it possible to explore the molecules that play i...
The recent discovery of cancer stem cells (CSCs), or tumor initiating cells (TICs), in a variety of ...
Agent-Based Modeling has been recently recognized as a method for in-silico multi-scale modeling of ...
Abstract Glioblastoma Multiforme is a brain cancer that still show poor prognosis for patients despi...
Multiscale agent-based modeling (MABM) has been widely used to simulate Glioblastoma Multiforme (GBM...
This dissertation presents how to use parallel computing algorithms on the basis of graphics process...
Multiscale agent-based modeling (MABM) has been widely used to simulate Glioblastoma Multiforme (GBM...
Glioblastoma (GBM) is the most common and fatal adult primary brain cancer. Maximal safe surgical re...
We have extended our previously developed 3D multi-scale agent-based brain tumor model to simulate c...
Glioblastoma multiforme (GBM) is the most lethal primary brain tumor characterized by high cellular ...
The temporal and spatial resolution in the microscopy of tissues has increased significa...
There have been several techniques developed in recent years to develop computer models of a variety...
Glioblastoma multiforme (GBM), a highly lethal brain cancer, accounts for over 30 percent of brain t...
Agent-based modeling (ABM) is an in silico technique that is being used in a variety of research are...
International audienceAn agent-based paradigm for the simulation of complex systems is based on the ...
This deliverable describes the agent-based model currently used in the Life Science use case of INFO...
The recent discovery of cancer stem cells (CSCs), or tumor initiating cells (TICs), in a variety of ...
Agent-Based Modeling has been recently recognized as a method for in-silico multi-scale modeling of ...
Abstract Glioblastoma Multiforme is a brain cancer that still show poor prognosis for patients despi...
Multiscale agent-based modeling (MABM) has been widely used to simulate Glioblastoma Multiforme (GBM...
This dissertation presents how to use parallel computing algorithms on the basis of graphics process...
Multiscale agent-based modeling (MABM) has been widely used to simulate Glioblastoma Multiforme (GBM...
Glioblastoma (GBM) is the most common and fatal adult primary brain cancer. Maximal safe surgical re...
We have extended our previously developed 3D multi-scale agent-based brain tumor model to simulate c...
Glioblastoma multiforme (GBM) is the most lethal primary brain tumor characterized by high cellular ...
The temporal and spatial resolution in the microscopy of tissues has increased significa...
There have been several techniques developed in recent years to develop computer models of a variety...
Glioblastoma multiforme (GBM), a highly lethal brain cancer, accounts for over 30 percent of brain t...
Agent-based modeling (ABM) is an in silico technique that is being used in a variety of research are...
International audienceAn agent-based paradigm for the simulation of complex systems is based on the ...
This deliverable describes the agent-based model currently used in the Life Science use case of INFO...
The recent discovery of cancer stem cells (CSCs), or tumor initiating cells (TICs), in a variety of ...
Agent-Based Modeling has been recently recognized as a method for in-silico multi-scale modeling of ...
Abstract Glioblastoma Multiforme is a brain cancer that still show poor prognosis for patients despi...